Skip to main content
Erschienen in: Virchows Archiv 5/2019

11.06.2019 | Original Article

Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland

verfasst von: Min-Shu Hsieh, Yung-Ming Jeng, Yi-Hsuan Lee

Erschienen in: Virchows Archiv | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Muscle, intestine, and stomach expression 1 (Mist1) is a transcription factor that functions in the development of granule organisation in serous exocrine cells of the gastrointestinal tract. The aim of this study was to investigate whether Mist1 can be used as a marker for acinic cell carcinoma (AciCC) of the salivary gland. Immunohistochemistry (IHC) was used to analyse Mist1 expression in AciCC (n = 26), secretory carcinoma (SC; n = 18) and 12 other types of salivary gland tumours (n = 99). Strong Mist1 staining was observed in normal serous acinar cells and plasma cells. Mist1 was diffusely expressed in AciCC, with the immunostaining intensity ranging from moderate (4/26) to strong (22/26). Most SC specimens were either negative (7/18) or focally and mildly positive (9/18) for Mist1. Only two SC cases demonstrated a moderate level of Mist1 staining. When moderate-to-strong Mist1 staining was used as the criterion of positivity, all the tested salivary gland tumours other than AciCC were negative for Mist1, except for two cases of SC. Previously cut tissue sections and decalcified specimens exhibited reduced Mist1 immunostaining intensity, which may give false-negative results. In summary, Mist1 is a sensitive marker for serous acinar cells of salivary glands and AciCC, and background non-tumour acinar cells and plasma cells can serve as good internal positive controls.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pin CL, Bonvissuto AC, Konieczny SF (2000) Mist1 expression is a common link among serous exocrine cells exhibiting regulated exocytosis. Anat Rec 259:157–167CrossRef Pin CL, Bonvissuto AC, Konieczny SF (2000) Mist1 expression is a common link among serous exocrine cells exhibiting regulated exocytosis. Anat Rec 259:157–167CrossRef
2.
Zurück zum Zitat Johnson CL, Kowalik AS, Rajakumar N, Pin CL (2004) Mist1 is necessary for the establishment of granule organization in serous exocrine cells of the gastrointestinal tract. Mech Dev 121:261–272CrossRef Johnson CL, Kowalik AS, Rajakumar N, Pin CL (2004) Mist1 is necessary for the establishment of granule organization in serous exocrine cells of the gastrointestinal tract. Mech Dev 121:261–272CrossRef
3.
Zurück zum Zitat Pin CL, Rukstalis JM, Johnson C, Konieczny SF (2001) The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J Cell Biol 155:519–530CrossRef Pin CL, Rukstalis JM, Johnson C, Konieczny SF (2001) The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J Cell Biol 155:519–530CrossRef
4.
Zurück zum Zitat Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK, Mills JC (2010) The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol 177:1514–1533CrossRef Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK, Mills JC (2010) The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol 177:1514–1533CrossRef
5.
Zurück zum Zitat Lemercier C, To RQ, Swanson BJ, Lyons GE, Konieczny SF (1997) Mist1: a novel basic helix-loop-helix transcription factor exhibits a developmentally regulated expression pattern. Dev Biol 182:101–113CrossRef Lemercier C, To RQ, Swanson BJ, Lyons GE, Konieczny SF (1997) Mist1: a novel basic helix-loop-helix transcription factor exhibits a developmentally regulated expression pattern. Dev Biol 182:101–113CrossRef
6.
Zurück zum Zitat Yeung CC, Mills JC, Hassan A, Kreisel FH, Nguyen TT, Frater JL (2012) MIST1-a novel marker of plasmacytic differentiation. Appl Immunohistochem Mol Morphol 20:561–565CrossRef Yeung CC, Mills JC, Hassan A, Kreisel FH, Nguyen TT, Frater JL (2012) MIST1-a novel marker of plasmacytic differentiation. Appl Immunohistochem Mol Morphol 20:561–565CrossRef
7.
Zurück zum Zitat Capoccia BJ, Lennerz JK, Bredemeyer AJ, Klco JM, Frater JL, Mills JC (2011) Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells. Physiol Genomics 43:174–186CrossRef Capoccia BJ, Lennerz JK, Bredemeyer AJ, Klco JM, Frater JL, Mills JC (2011) Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells. Physiol Genomics 43:174–186CrossRef
8.
Zurück zum Zitat Simpson RHW, Chiosea S, Katabi N, Leivo I, Vielh P, Williams MD (2017) Acinic cell carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Sllotweg PJ (eds) World Health Organization classification of head and neck tumours. IARC Press, Lyon, pp 166–167 Simpson RHW, Chiosea S, Katabi N, Leivo I, Vielh P, Williams MD (2017) Acinic cell carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Sllotweg PJ (eds) World Health Organization classification of head and neck tumours. IARC Press, Lyon, pp 166–167
9.
Zurück zum Zitat Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, Hyrcza M, Rupp NJ, Baneckova M, Michal M Jr, Slouka D, Svoboda T, Metelkova A, Etebarian A, Pavelka J, Potts SJ, Christiansen J, Steiner P, Michal M (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42:234–246CrossRef Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, Hyrcza M, Rupp NJ, Baneckova M, Michal M Jr, Slouka D, Svoboda T, Metelkova A, Etebarian A, Pavelka J, Potts SJ, Christiansen J, Steiner P, Michal M (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42:234–246CrossRef
10.
Zurück zum Zitat Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599–608PubMed Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599–608PubMed
11.
Zurück zum Zitat Skálová A, Bell D, Bishop JA, Inagaki H, Seethala R, Vielh P (2017) Secretory carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Sllotweg PJ (eds) World Health Organization classification of head and neck tumours. IARC Press, Lyon, p 177 Skálová A, Bell D, Bishop JA, Inagaki H, Seethala R, Vielh P (2017) Secretory carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Sllotweg PJ (eds) World Health Organization classification of head and neck tumours. IARC Press, Lyon, p 177
12.
Zurück zum Zitat Chênevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR (2012) DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 25:919–929CrossRef Chênevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR (2012) DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 25:919–929CrossRef
13.
Zurück zum Zitat Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH (2013) Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol 44:1982–1988CrossRef Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH (2013) Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol 44:1982–1988CrossRef
14.
Zurück zum Zitat Patel KR, Solomon IH, El-Mofty SK, Lewis JS Jr, Chernock RD (2013) Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol 44:2501–2508CrossRef Patel KR, Solomon IH, El-Mofty SK, Lewis JS Jr, Chernock RD (2013) Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol 44:2501–2508CrossRef
15.
Zurück zum Zitat Mariano FV, Gómez CA, de Souza do Nascimento J, Dos Santos HT, Egal ES, Montalli VA, Vargas PA, de Almeida OP, Altemani A (2016) Lysozyme expression can be useful to distinguish mammary analog secretory carcinoma from acinic cell carcinoma of salivary glands. Head Neck Pathol 10:429–436CrossRef Mariano FV, Gómez CA, de Souza do Nascimento J, Dos Santos HT, Egal ES, Montalli VA, Vargas PA, de Almeida OP, Altemani A (2016) Lysozyme expression can be useful to distinguish mammary analog secretory carcinoma from acinic cell carcinoma of salivary glands. Head Neck Pathol 10:429–436CrossRef
16.
Zurück zum Zitat Hsieh MS, Jeng YM, Jhuang YL, Chou YH, Lin CY (2016) Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland. Histopathology 68:641–647CrossRef Hsieh MS, Jeng YM, Jhuang YL, Chou YH, Lin CY (2016) Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland. Histopathology 68:641–647CrossRef
17.
Zurück zum Zitat Hsieh MS, Chou YH, Yeh SJ, Chang YL (2015) Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. Virchows Arch 467:145–153CrossRef Hsieh MS, Chou YH, Yeh SJ, Chang YL (2015) Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. Virchows Arch 467:145–153CrossRef
18.
Zurück zum Zitat Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291–299PubMed Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291–299PubMed
19.
Zurück zum Zitat Skálová A, Sima R, Vanecek T, Muller S, Korabecna M, Nemcova J, Elmberger G, Leivo I, Passador-Santos F, Walter J, Rousarova M, Jedlickova K, Curik R, Geierova M, Michal M (2009) Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol 33:1137–1145CrossRef Skálová A, Sima R, Vanecek T, Muller S, Korabecna M, Nemcova J, Elmberger G, Leivo I, Passador-Santos F, Walter J, Rousarova M, Jedlickova K, Curik R, Geierova M, Michal M (2009) Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol 33:1137–1145CrossRef
20.
Zurück zum Zitat Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H (2013) SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 26:1041–1050CrossRef Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H (2013) SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 26:1041–1050CrossRef
21.
Zurück zum Zitat Athwal HK, Murphy G 3rd, Tibbs E, Cornett A, Hill E, Yeoh K, Berenstein E, Hoffman MP, Lombaert IMA (2019) Sox10 regulates plasticity of epithelial progenitors toward secretory units of exocrine glands. Stem Cell Reports 12:366–380CrossRef Athwal HK, Murphy G 3rd, Tibbs E, Cornett A, Hill E, Yeoh K, Berenstein E, Hoffman MP, Lombaert IMA (2019) Sox10 regulates plasticity of epithelial progenitors toward secretory units of exocrine glands. Stem Cell Reports 12:366–380CrossRef
22.
Zurück zum Zitat Hsieh MS, Lee YH, Chang YL (2016) SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum Pathol 56:134–142CrossRef Hsieh MS, Lee YH, Chang YL (2016) SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum Pathol 56:134–142CrossRef
23.
Zurück zum Zitat Andreasen S, Varma S, Barasch N, Thompson LDR, Miettinen M, Rooper L, Stelow EB, Agander TK, Seethala RR, Chiosea SI, Homøe P, Wessel I, Larsen SR, Erentaite D, Bishop JA, Ulhøi BP, Kiss K, Melchior LC, Pollack JR, West RB (2019) The HTN3-MSANTD3 fusion gene defines a subset of acinic cell carcinoma of the salivary gland. Am J Surg Pathol 43:489–496CrossRef Andreasen S, Varma S, Barasch N, Thompson LDR, Miettinen M, Rooper L, Stelow EB, Agander TK, Seethala RR, Chiosea SI, Homøe P, Wessel I, Larsen SR, Erentaite D, Bishop JA, Ulhøi BP, Kiss K, Melchior LC, Pollack JR, West RB (2019) The HTN3-MSANTD3 fusion gene defines a subset of acinic cell carcinoma of the salivary gland. Am J Surg Pathol 43:489–496CrossRef
24.
Zurück zum Zitat Mirlacher M, Kasper M, Storz M, Knecht Y, Dürmüller U, Simon R, Mihatsch MJ, Sauter G (2004) Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol 17:1414–1420CrossRef Mirlacher M, Kasper M, Storz M, Knecht Y, Dürmüller U, Simon R, Mihatsch MJ, Sauter G (2004) Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol 17:1414–1420CrossRef
Metadaten
Titel
Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland
verfasst von
Min-Shu Hsieh
Yung-Ming Jeng
Yi-Hsuan Lee
Publikationsdatum
11.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2019
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-019-02600-1

Weitere Artikel der Ausgabe 5/2019

Virchows Archiv 5/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …